Publications by authors named "David R Fermin"

Claim this Profile
L
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks: Insights From the VALOR-HCM Trial.
Milind Y Desai, Yuichiro Okushi, Kathy Wolski, Jeffrey B Geske, Anjali Tiku Owens, David R Fermin

JACC Cardiovasc Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.
Milind Y Desai, Sara Saberi, Jeffrey B Geske, Andrew Wang, Paul Cremer, David R Fermin

JACC Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, molecular, and genomic changes in response to a left ventricular assist device.
Jennifer L Hall, David R Fermin, Emma J Birks, Paul J R Barton, Mark Slaughter

J Am Coll Cardiol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex and age dimorphism of myocardial gene expression in nonischemic human heart failure.
David R Fermin, Ana Barac, Sangjin Lee, Sean P Polster, Sridhar Hannenhalli

Circ Cardiovasc Genet· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis